Nutex Health (NASDAQ:NUTX) Earns Buy Rating from Analysts at B. Riley Financial

Analysts at B. Riley Financial assumed coverage on shares of Nutex Health (NASDAQ:NUTX) in a report released on Friday. The firm set a “buy” rating and a $325.00 price target on the stock. B. Riley Financial’s target price indicates a potential upside of 69.50% from the stock’s current price.

Several other equities analysts also recently issued reports on NUTX. Zacks Research raised shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. Lake Street Capital reiterated a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Wall Street Zen lowered Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 20th. Finally, Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Nutex Health presently has an average rating of “Buy” and an average target price of $317.50.

Nutex Health Price Performance

NUTX stock traded down $5.95 during trading on Friday, hitting $191.74. The company had a trading volume of 20,394 shares, compared to its average volume of 170,225. The company has a fifty day moving average price of $175.06 and a two-hundred day moving average price of $136.35. Nutex Health has a fifty-two week low of $80.53 and a fifty-two week high of $204.00. The company has a market cap of $1.31 billion, a P/E ratio of 7.53 and a beta of 0.28. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The firm had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million.

Hedge Funds Weigh In On Nutex Health

A number of institutional investors have recently modified their holdings of NUTX. California State Teachers Retirement System grew its stake in shares of Nutex Health by 25,615.8% during the second quarter. California State Teachers Retirement System now owns 934,768 shares of the company’s stock valued at $159,743,000 after purchasing an additional 931,133 shares during the last quarter. BlackRock Inc. bought a new position in Nutex Health in the 2nd quarter worth approximately $69,612,000. Topline Capital Management LLC lifted its holdings in Nutex Health by 72.0% during the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company’s stock worth $38,484,000 after buying an additional 129,418 shares in the last quarter. Winmill & CO. Inc. acquired a new position in Nutex Health during the 2nd quarter worth $11,168,000. Finally, Millennium Management LLC boosted its position in Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock valued at $9,650,000 after buying an additional 61,308 shares during the last quarter. 5.32% of the stock is owned by institutional investors.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.